Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXQ5OD
|
||||
| Drug Name |
1-(3-Benzo[b]thiophen-2-yl-8-aza-bicyclo[3.2.1]oct-8-yl)-3-(1H-indol-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL309666
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H28N2O2S
|
||||
| Canonical SMILES |
O[C@H](COc1cccc2[nH]ccc12)CN3[C@@H]4CC[C@H]3C[C@@H](C4)c5cc6ccccc6s5
|
||||
| InChI |
InChI=1S/C26H28N2O2S/c29-21(16-30-24-6-3-5-23-22(24)10-11-27-23)15-28-19-8-9-20(28)13-18(12-19)26-14-17-4-1-2-7-25(17)31-26/h1-7,10-11,14,18-21,27,29H,8-9,12-13,15-16H2/t18-,19-,20+,21-/m0/s1
|
||||
| InChIKey |
QCXQLGPXPZCQFK-BURNTYAHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.